tirzepatide vs semaglutide weight loss effectiveness comparison for in Adults With Overweight or Obesity tirzepatide vs semaglutide weight loss

Secondary analyses assessed incidence of HR-positive/HER2-positive, HR-negative/HER2-positive, and triple-negative (HR-negative/HER2-negative) breast cancer subtypes

At that pace the NHS will treat fewer patients in three years than private providers handle in four weeks

Bland JS et al

doi: 10.1128/jb.85.4.842-850.1963 247 WhittakerR.EconomopoulouA.DiasJ

Ideal candidates are adults with a BMI in the overweight or obese range, or those struggling with weight-related health concerns

Given the strong link found between low body mass index and decreased survival with ALS (Paganoni et al., 2011), a randomized double blind phase 2 clinical study was performed in small number of patients with ALS to test the safety and tolerability of high caloric diets, which were either high in carbohydrates or high in fat